Risk of suicide ideation in comorbid substance use disorder and major depression
- PMID: 36477246
- PMCID: PMC9728854
- DOI: 10.1371/journal.pone.0265287
Risk of suicide ideation in comorbid substance use disorder and major depression
Abstract
Background: Suicidal behaviour is commonly associated with major depression (MD) and substance use disorders (SUDs). However, there is a paucity of research on risk for suicide ideation among individuals with comorbid SUDs and MD in the general population.
Objectives: This study investigated the associated risk of suicide ideation in comorbid SUDs-cannabis use disorder (CUD), alcohol use disorder (AUD), drug use disorder (DUD) with major depressive episode (MDE) in a nationally representative sample.
Methods: Multilevel logistic regression models were used to analyze the 2012 Canadian Community Health Survey- Mental Health (CCHS-MH) data. This is a cross-sectional survey of nationally representative samples of Canadians (n = 25,113) aged 15 years and older residing in the ten Canadian provinces between January and December 2012. Diagnoses of MDE, AUD, DUD, and CUD were based on a modified WHO-CIDI, derived from DSM-IV diagnostic criteria.
Results: Comorbidity was found to be the strongest predictor of suicide ideation. Compared to those with no diagnosis of either a SUD or MDE, individuals with a comorbid diagnosis of AUD with MDE, CUD with MDE, or DUD with MDE were 9, 11 and 16 times more likely to have 12-month suicide ideation respectively. A diagnosis of MDE was a significant predictor of 12-month suicide ideation with about a 7-fold increased risk compared with individuals not diagnosed with either MDE or a SUD.
Conclusion: Suicide is a preventable public health issue. Our study found a significantly increased risk of suicide ideation among persons who have comorbid SUD with MD. Effective integration of mental health and addictions services could mitigate the risk of suicide and contribute to better outcomes.
Copyright: © 2022 Onaemo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Comorbid substance use disorder, major depression, and associated disability in a nationally representative sample.J Affect Disord. 2024 Mar 1;348:8-16. doi: 10.1016/j.jad.2023.12.016. Epub 2023 Dec 7. J Affect Disord. 2024. PMID: 38070745
-
Associations of Suicidality Trends With Cannabis Use as a Function of Sex and Depression Status.JAMA Netw Open. 2021 Jun 1;4(6):e2113025. doi: 10.1001/jamanetworkopen.2021.13025. JAMA Netw Open. 2021. PMID: 34156452 Free PMC article.
-
Temporal Changes in the Cross-Sectional Associations between Cannabis Use, Suicidal Ideation, and Depression in a Nationally Representative Sample of Canadian Adults in 2012 Compared to 2002.Can J Psychiatry. 2020 Feb;65(2):115-123. doi: 10.1177/0706743719854071. Epub 2019 Jun 9. Can J Psychiatry. 2020. PMID: 31177831 Free PMC article.
-
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Ann Clin Psychiatry. 2012. PMID: 22303521 Review.
-
Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.J Affect Disord. 2021 Feb 15;281:467-475. doi: 10.1016/j.jad.2020.12.043. Epub 2020 Dec 16. J Affect Disord. 2021. PMID: 33360749
Cited by
-
Mental Health Treatment Use, Perceived Treatment Need, and Reasons for Non-Use Among U.S. Adults with Serious Suicidal Thoughts During the COVID-19 Pandemic.Community Ment Health J. 2024 Jul;60(5):972-984. doi: 10.1007/s10597-024-01249-8. Epub 2024 Feb 19. Community Ment Health J. 2024. PMID: 38372825
-
Suicide deaths and substance use in the Galician provinces between 2006 and 2020.Front Psychiatry. 2023 Aug 14;14:1242069. doi: 10.3389/fpsyt.2023.1242069. eCollection 2023. Front Psychiatry. 2023. PMID: 37645637 Free PMC article.
-
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.Transl Psychiatry. 2024 May 29;14(1):221. doi: 10.1038/s41398-024-02923-x. Transl Psychiatry. 2024. PMID: 38811559 Free PMC article.
-
Alcohol consumption associated with suicidal ideation, and suicide attempts in substance users: A cross-sectional study of an addiction registry in western Iran.PLoS One. 2025 Feb 4;20(2):e0317456. doi: 10.1371/journal.pone.0317456. eCollection 2025. PLoS One. 2025. PMID: 39903791 Free PMC article.
-
Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale.J Affect Disord Rep. 2024 Jan;15:100690. doi: 10.1016/j.jadr.2023.100690. Epub 2023 Dec 2. J Affect Disord Rep. 2024. PMID: 38283689 Free PMC article.
References
-
- World Health Organization. Suicide worldwide in 2019: global health estimates. Geneva; 2021.
-
- World Health Organization. Preventing suicide: a global imperative. Geneva, Switzerland:; 2014.